Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

79759

registered interest
date	29/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what measures they are taking to support research into paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1651
answer	answer is ministerial correction date of answer 18/08/2014 answer text <p>The Department's National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including gastrointestinal stromal tumours (GIST). These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and the National Health Service, value for money and scientific quality.</p><p> </p><p>NIHR research infrastructure including NIHR biomedical research centres and the NIHR Clinical Research Network are hosting studies in GIST including a phase I/II study of sunitinib in young patients with advanced GIST.</p> answering member printed Earl Howe question first answered 18/08/2014 10:09:33 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79760

registered interest
date	29/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what measures they are taking to improve diagnosis and treatment of paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1652
answer	answer is ministerial correction date of answer 18/08/2014 answer text <p>Measures to ensure early diagnosis of cancer, including rare cancers, are discussed monthly by the Public Awareness and Primary Care Steering Group. The group is chaired by Sean Duffy, NHS England’s National Clinical Director for Cancer, and includes members representing Public Health England, Cancer Research UK, Macmillan Cancer Support and Departmental officials and other stakeholders.</p><p> </p><p>As rare cancers, paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumours (PAWS GIST) are covered by the 2013-14 NHS standard contract for paediatric oncology which was developed by the Specialised Service Children’s Cancer Clinical Reference Group (CRG) and can be found at the following address:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/e04-paedi-oncol.pdf</p><p> </p><p>NHS England has no plans to establish a specialist PAWS GIST clinic, as treatment is currently provided through paediatric oncology services.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p>GIST Support UK have in partnership with Addenbrookes Hospital in Cambridge, established a PAWS GIST clinic that is led by Dr Ramesh Bulusu working with a UK national alliance of doctors.</p><p> </p><p>Dr Jacqueline Cornish, National Clinical Director for Children, Young People and Transition to Adulthood, NHS England has responsibility for PAWS GIST.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1653 HL1654 HL1655 question first answered 18/08/2014 10:09:04 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79761

registered interest
date	29/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what progress has been made in giving paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer specialised commissioning status.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1653
answer	answer is ministerial correction date of answer 18/08/2014 answer text <p>Measures to ensure early diagnosis of cancer, including rare cancers, are discussed monthly by the Public Awareness and Primary Care Steering Group. The group is chaired by Sean Duffy, NHS England’s National Clinical Director for Cancer, and includes members representing Public Health England, Cancer Research UK, Macmillan Cancer Support and Departmental officials and other stakeholders.</p><p> </p><p>As rare cancers, paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumours (PAWS GIST) are covered by the 2013-14 NHS standard contract for paediatric oncology which was developed by the Specialised Service Children’s Cancer Clinical Reference Group (CRG) and can be found at the following address:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/e04-paedi-oncol.pdf</p><p> </p><p>NHS England has no plans to establish a specialist PAWS GIST clinic, as treatment is currently provided through paediatric oncology services.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p>GIST Support UK have in partnership with Addenbrookes Hospital in Cambridge, established a PAWS GIST clinic that is led by Dr Ramesh Bulusu working with a UK national alliance of doctors.</p><p> </p><p>Dr Jacqueline Cornish, National Clinical Director for Children, Young People and Transition to Adulthood, NHS England has responsibility for PAWS GIST.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1652 HL1654 HL1655 question first answered 18/08/2014 10:09:04 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79762

registered interest
date	29/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government which National Clinical Director has responsibility for paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer patients.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1654
answer	answer is ministerial correction date of answer 18/08/2014 answer text <p>Measures to ensure early diagnosis of cancer, including rare cancers, are discussed monthly by the Public Awareness and Primary Care Steering Group. The group is chaired by Sean Duffy, NHS England’s National Clinical Director for Cancer, and includes members representing Public Health England, Cancer Research UK, Macmillan Cancer Support and Departmental officials and other stakeholders.</p><p> </p><p>As rare cancers, paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumours (PAWS GIST) are covered by the 2013-14 NHS standard contract for paediatric oncology which was developed by the Specialised Service Children’s Cancer Clinical Reference Group (CRG) and can be found at the following address:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/e04-paedi-oncol.pdf</p><p> </p><p>NHS England has no plans to establish a specialist PAWS GIST clinic, as treatment is currently provided through paediatric oncology services.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p>GIST Support UK have in partnership with Addenbrookes Hospital in Cambridge, established a PAWS GIST clinic that is led by Dr Ramesh Bulusu working with a UK national alliance of doctors.</p><p> </p><p>Dr Jacqueline Cornish, National Clinical Director for Children, Young People and Transition to Adulthood, NHS England has responsibility for PAWS GIST.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1652 HL1653 HL1655 question first answered 18/08/2014 10:09:04 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79763

registered interest
date	29/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what plans they have to establish a specialist paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer clinic in the United Kingdom.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1655
answer	answer is ministerial correction date of answer 18/08/2014 answer text <p>Measures to ensure early diagnosis of cancer, including rare cancers, are discussed monthly by the Public Awareness and Primary Care Steering Group. The group is chaired by Sean Duffy, NHS England’s National Clinical Director for Cancer, and includes members representing Public Health England, Cancer Research UK, Macmillan Cancer Support and Departmental officials and other stakeholders.</p><p> </p><p>As rare cancers, paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumours (PAWS GIST) are covered by the 2013-14 NHS standard contract for paediatric oncology which was developed by the Specialised Service Children’s Cancer Clinical Reference Group (CRG) and can be found at the following address:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/e04-paedi-oncol.pdf</p><p> </p><p>NHS England has no plans to establish a specialist PAWS GIST clinic, as treatment is currently provided through paediatric oncology services.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p>GIST Support UK have in partnership with Addenbrookes Hospital in Cambridge, established a PAWS GIST clinic that is led by Dr Ramesh Bulusu working with a UK national alliance of doctors.</p><p> </p><p>Dr Jacqueline Cornish, National Clinical Director for Children, Young People and Transition to Adulthood, NHS England has responsibility for PAWS GIST.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1652 HL1653 HL1654 question first answered 18/08/2014 10:09:03 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79764

registered interest
date	29/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neurofibromatosis
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what action they are taking to ensure early diagnosis of patients with neurofibromatosis type 1.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1656
answer	answer is ministerial correction date of answer 18/08/2014 answer text <p><strong>Information for the public on the diagnosis and treatment of n</strong>eurofibromatosis<strong>type 1 (NF1) can be found on the NHS Choices website, which sets out the key signs and symptoms of the condition, including: coffee colored patches on the skin, two or more neurofibromas (bumps on or under the skin); bone defects, such as bowing of the lower leg; and, a family history of NF1. The NF1 webpages can be viewed at the following link:</strong></p><p><strong> </strong></p><p><strong>www.nhs.uk/conditions/Neurofibromatosis/Pages/Introduction.aspx </strong></p><p><strong> </strong></p><p><strong>More detailed information for general practitioners and other health professionals can be found on the National Institute for Health and Care Excellence NHS Evidence website at:</strong></p><p><strong> </strong></p><p><strong>www.evidence.nhs.uk</strong></p><p><strong> </strong></p><p><strong>This </strong>provides free access to quality health and social care evidence and best practice.</p><p> </p><p>NHS England commissions complex NF1 services as part of its remit to deliver specialised services and has published a service specification for NF1. Diagnostic services are a core element of this specification and can be accessed by all patients with a suspected or confirmed diagnosis on referral.</p> answering member printed Earl Howe question first answered 18/08/2014 10:08:22 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79644

registered interest
date	28/07/2014
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Schools: Radicalism
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether, in the review commissioned by the Secretary of State for Education into whether the Department missed historical warnings in respect of concerns raised about Birmingham schools, the Permanent Secretary intends to interview Mr Tim Boyes, headteacher of Queensbridge School.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1536
answer	answer is ministerial correction date of answer 30/07/2014 answer text <p>Given that the Permanent Secretary’s review is ongoing, it would not be appropriate to comment on details regarding the conduct of the review. The Permanent Secretary will be reporting to the Secretary of State later in the summer.</p> answering member printed Lord Nash grouped question UIN HL1537 question first answered 30/07/2014 13:50:48 answering member 4270 label Biography information for Lord Nash
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79645

registered interest
date	28/07/2014
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Schools: Radicalism
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether, in the review commissioned by the Secretary of State for Education into whether the Department missed historical warnings in respect of concerns raised about Birmingham schools, the Permanent Secretary intends to interview Lord Hunt of Kings Heath.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1537
answer	answer is ministerial correction date of answer 30/07/2014 answer text <p>Given that the Permanent Secretary’s review is ongoing, it would not be appropriate to comment on details regarding the conduct of the review. The Permanent Secretary will be reporting to the Secretary of State later in the summer.</p> answering member printed Lord Nash grouped question UIN HL1536 question first answered 30/07/2014 13:50:47 answering member 4270 label Biography information for Lord Nash
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79646

registered interest
date	28/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neurofibromatosis
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government out of all known patients with neurofibromatosis Type 1, how many were treated in the last 12 months at the two designated national specialist care centres.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1538
answer	answer is ministerial correction date of answer 18/08/2014 answer text <p>Whilst the number of people with neurofibromatosis Type 1 (NF1) in England is estimated to number 11,267, the number of patients with a confirmed diagnosis is not collected.</p><p> </p><p>In the following table we have provided the number of finished admission episodes (FAEs) for patients with a primary diagnosis of NF1 who were treated at the two national specialist centres in 2012-13, the most recent period for which data is available. An FAE is a continuous period of admitted patient care under one consultant within one health care provider. It should be noted the figures do not represent a count of patients, as a person may have more than one episode of care within the same stay in hospital or in different stays in the same year.</p><p> </p><p> </p><table><tbody><tr><td colspan="2"><p>FAEs in 2012-13 for patients with primary or secondary diagnosis of NF1 (non-malignant)</p><p> </p></td></tr><tr><td><p>Trust</p></td><td><p>Numbers</p></td></tr><tr><td><p>Central Manchester University Hospitals NHS Foundation Trust</p></td><td><p>213</p></td></tr><tr><td><p>Guys and St. Thomas’ NHS Foundation Trust</p></td><td><p>124</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p><p><em>Source:</em> Hospital Episode Statistics (HES), Health and Social Care Information Centre</p><p> </p><p>Information concerning the number of patients waiting to be treated at the two national centres is not available.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1539 question first answered 18/08/2014 10:18:05 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79647

registered interest
date	28/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neurofibromatosis
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many patients with neurofibromatosis Type 1 are waiting to be treated at the two designated national specialist care centres.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1539
answer	answer is ministerial correction date of answer 18/08/2014 answer text <p>Whilst the number of people with neurofibromatosis Type 1 (NF1) in England is estimated to number 11,267, the number of patients with a confirmed diagnosis is not collected.</p><p> </p><p>In the following table we have provided the number of finished admission episodes (FAEs) for patients with a primary diagnosis of NF1 who were treated at the two national specialist centres in 2012-13, the most recent period for which data is available. An FAE is a continuous period of admitted patient care under one consultant within one health care provider. It should be noted the figures do not represent a count of patients, as a person may have more than one episode of care within the same stay in hospital or in different stays in the same year.</p><p> </p><p> </p><table><tbody><tr><td colspan="2"><p>FAEs in 2012-13 for patients with primary or secondary diagnosis of NF1 (non-malignant)</p><p> </p></td></tr><tr><td><p>Trust</p></td><td><p>Numbers</p></td></tr><tr><td><p>Central Manchester University Hospitals NHS Foundation Trust</p></td><td><p>213</p></td></tr><tr><td><p>Guys and St. Thomas’ NHS Foundation Trust</p></td><td><p>124</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p><p><em>Source:</em> Hospital Episode Statistics (HES), Health and Social Care Information Centre</p><p> </p><p>Information concerning the number of patients waiting to be treated at the two national centres is not available.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1538 question first answered 18/08/2014 10:18:04 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath